Multiomics and functional studies have suggested that tumor-intrinsic S100A1 expression correlated with an immunologically “cold” TME and resistance to ICB in multiple syngeneic murine tumors and tissue samples from patients with lung cancer. The gene discussed is S100A1; the disease is lung cancer.